These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37935744)

  • 21. Peripheral Complement Factor-Based Biomarkers for Patients with First-Episode Schizophrenia.
    Cao Y; Xu Y; Xia Q; Shan F; Liang J
    Neuropsychiatr Dis Treat; 2023; 19():1455-1462. PubMed ID: 37384352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline high levels of complement component 4 predict worse clinical outcome at 1-year follow-up in first-episode psychosis.
    Mondelli V; Di Forti M; Morgan BP; Murray RM; Pariante CM; Dazzan P
    Brain Behav Immun; 2020 Aug; 88():913-915. PubMed ID: 31981599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels.
    Akcan U; Karabulut S; İsmail Küçükali C; Çakır S; Tüzün E
    Acta Neuropsychiatr; 2018 Apr; 30(2):70-78. PubMed ID: 28399943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
    Çakici N; Sutterland AL; Penninx BWJH; Dalm VA; de Haan L; van Beveren NJM
    Brain Behav Immun; 2020 Aug; 88():547-558. PubMed ID: 32330592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum complement components in Henoch-Schönlein purpura.
    Garcia-Fuentes M; Martin A; Chantler C; Williams DG
    Arch Dis Child; 1978 May; 53(5):417-9. PubMed ID: 666358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement C3 and C4, but not their regulators or activated products, are associated with incident metabolic syndrome: the CODAM study.
    Xin Y; Hertle E; van der Kallen CJH; Schalkwijk CG; Stehouwer CDA; van Greevenbroek MMJ
    Endocrine; 2018 Dec; 62(3):617-627. PubMed ID: 30132263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of complement component C4 in the dorsolateral prefrontal cortex, parietal cortex, superior temporal gyrus and associative striatum of patients with schizophrenia.
    Rey R; Suaud-Chagny MF; Bohec AL; Dorey JM; d'Amato T; Tamouza R; Leboyer M
    Brain Behav Immun; 2020 Nov; 90():216-225. PubMed ID: 32827700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shared and distinct structural brain alterations and cognitive features in drug-naïve schizophrenia and bipolar disorder.
    Zhang W; Du JL; Fang XY; Ni LY; Zhu YY; Yan W; Lu SP; Zhang RR; Xie SP
    Asian J Psychiatr; 2023 Apr; 82():103513. PubMed ID: 36827938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of altered cortical gyrification and psychopathological symptoms in patients with first-episode drug-naïve schizophrenia.
    Zhou H; Wang D; Wang J; Xu H; Cao B; Zhang X
    Asian J Psychiatr; 2021 Oct; 64():102749. PubMed ID: 34334350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between function and structure of the triple network and catechol-O-methyltransferase val
    Kang Y; Huang K; Cai S; Wang H; Liu J; Wang Y; Lv Y; Zhang W; Wang Q; Huang L; Wang J; Tian J
    Neurosci Lett; 2018 Nov; 687():65-70. PubMed ID: 30240822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia.
    Purves-Tyson TD; Robinson K; Brown AM; Boerrigter D; Cai HQ; Weissleder C; Owens SJ; Rothmond DA; Shannon Weickert C
    Front Immunol; 2020; 11():2002. PubMed ID: 33133060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical thickness in first-episode schizophrenia patients and individuals at high familial risk: a cross-sectional comparison.
    Sprooten E; Papmeyer M; Smyth AM; Vincenz D; Honold S; Conlon GA; Moorhead TW; Job D; Whalley HC; Hall J; McIntosh AM; Owens DC; Johnstone EC; Lawrie SM
    Schizophr Res; 2013 Dec; 151(1-3):259-64. PubMed ID: 24120958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of age and sex on serum complement components in children.
    Roach B; Kim Y; Jerome E; Michael AF
    Am J Dis Child; 1981 Oct; 135(10):918-20. PubMed ID: 6975036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia.
    Fernandez VG; Asarnow R; Narr KL; Subotnik KL; Kuppinger H; Fogelson D; Nuechterlein KH
    Schizophr Res; 2018 Sep; 199():221-225. PubMed ID: 29499968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum hyperhomocysteine and cognitive impairment in first-episode patients with schizophrenia: Moderated by brain cortical thickness.
    Lin C; Gou M; Pan S; Tong J; Zhou Y; Xie T; Yu T; Feng W; Li Y; Chen S; Tian B; Tan S; Wang Z; Luo X; Li CR; Zhang P; Huang J; Elliot Hong L; Tan Y
    Neurosci Lett; 2022 Sep; 788():136826. PubMed ID: 35944595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels of lymphocyte-associated regulators of complement system CD55 and CD59 are changed in schizophrenia patients.
    Togay A; Togay B; Ozbay Gediz D; Akbaş SH; Köksoy S
    Int J Psychiatry Clin Pract; 2021 Sep; 25(3):277-282. PubMed ID: 34154502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of complement components C1q and C4 bound to circulating immune complexes in juvenile idiopathic arthritis: support for classical complement pathway activation.
    Gilliam BE; Reed MR; Chauhan AK; Dehlendorf AB; Moore TL
    Clin Exp Rheumatol; 2011; 29(6):1049-56. PubMed ID: 22153664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetically predicted complement component 4A expression: effects on memory function and middle temporal lobe activation.
    Donohoe G; Holland J; Mothersill D; McCarthy-Jones S; Cosgrove D; Harold D; Richards A; Mantripragada K; Owen MJ; O'Donovan MC; ; Gill M; Corvin A; Morris DW
    Psychol Med; 2018 Jul; 48(10):1608-1615. PubMed ID: 29310738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Components of the Complement Cascade Differ in Polycystic Ovary Syndrome.
    Butler AE; Moin ASM; Sathyapalan T; Atkin SL
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293087
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The complement system in schizophrenia: where are we now and what's next?
    Woo JJ; Pouget JG; Zai CC; Kennedy JL
    Mol Psychiatry; 2020 Jan; 25(1):114-130. PubMed ID: 31439935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.